These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 16100005

  • 1. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation.
    Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, Fiaccavento R, Carotenuto F, De Vito P, Baldini PM, Prat M, Di Nardo P.
    Stem Cells; 2006 Jan; 24(1):23-33. PubMed ID: 16100005
    [Abstract] [Full Text] [Related]

  • 2. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 3. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, Christensen JG, Waage A, Sundan A, Børset M.
    Clin Cancer Res; 2004 Oct 01; 10(19):6686-94. PubMed ID: 15475459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.
    Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A.
    Stem Cells; 2006 May 01; 24(5):1254-64. PubMed ID: 16410389
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing.
    Neuss S, Becher E, Wöltje M, Tietze L, Jahnen-Dechent W.
    Stem Cells; 2004 May 01; 22(3):405-14. PubMed ID: 15153617
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27.
    Chen K, Perez-Stable C, D'Ippolito G, Schiller PC, Roos BA, Howard GA.
    Bone; 2011 Dec 15; 49(6):1194-204. PubMed ID: 21907315
    [Abstract] [Full Text] [Related]

  • 13. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R, Chen J, Cong X, Hu S, Chen X.
    J Cell Biochem; 2008 Jan 01; 103(1):256-69. PubMed ID: 17497701
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A, Götze T, Korc M.
    Cancer Res; 2007 Nov 01; 67(21):10309-16. PubMed ID: 17974973
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH.
    Chem Biol Interact; 2006 Mar 25; 160(2):123-33. PubMed ID: 16458870
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G.
    J Neurosci Res; 2003 Dec 01; 74(5):760-8. PubMed ID: 14635227
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
    Shin MK, Kim MK, Bae YS, Jo I, Lee SJ, Chung CP, Park YJ, Min do S.
    Cell Signal; 2008 Apr 01; 20(4):613-24. PubMed ID: 18248957
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 01; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.